Dependence of mesolimbic dopamine transmission on Δ9-tetrahydrocannabinol

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-07-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(99)00384-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesolimbic dopaminergic decline after cannabinoid withdrawal.

  1998cited by this paper
• A dopamine‐μ1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non‐psychostimulant drugs of abuse

  1998cited by this paper
• Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.

  1997cited by this paper
• Drug abuse: hedonic homeostatic dysregulation.

  1997cited by this paper
• Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

  1997cited by this paper
• Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

  1997cited by this paper
• Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.

  1995cited by this paper
• The role of dopamine in drug abuse viewed from the perspective of its role in motivation

  1995cited by this paper
• Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

  1995cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Dopamine, γ-aminobutyric acid, and glutamate balance in the nucleus accumbens shell: Differential effects of cannabinoid 1 receptor agonists Δ9-Tetrahydrocannabinol, AM11101, and AM8936.

  2026cites this paper
• Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal

  2024cites this paper
• Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism

  2022cites this paper
• Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings

  2021cites this paper
• Long lasting effects of chronic WIN55,212–2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain

  2018cites this paper
• Geschichte eines Suchtbegriffs, Ätiologie und Epidemiologie der Sucht

  2018cites this paper
• Dopamine and addiction: what have we learned from 40 years of research

  2018cites this paper
• The Impact of Cannabinoids on Motor Activity and Neurochemical Correlates

  2017cites this paper
• Drug addiction: An affective-cognitive disorder in need of a cure.

  2016cites this paper
• Keep off the grass? Cannabis, cognition and addiction

  2016cites this paper
• Molecular Mechanisms of Cannabis Signaling in the Brain.

  2016cites this paper
• Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function.

  2015cites this paper
• A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.

  2015cites this paper
• quale paradigma di sintomi negativi nell'abuso di sostanze

  2015cites this paper
• Acute and chronic effects of cannabinoids on human brain: gene-environment interactions related to psychiatric disorders

  2014cites this paper
• Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.

  2014cites this paper
• Evaluation of sex differences in cannabinoid dependence.

  2014cites this paper
• Cannabinoid type-1 receptor ligands, alone or in combination with cocaine, affect vigilance-related behaviors of marmoset monkeys.

  2014cites this paper
• Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell

  2014cites this paper
• Hampered long-term depression and thin spine loss in the nucleus accumbens of ethanol-dependent rats

  2014cites this paper
• Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse.

  2013cites this paper
• Role of the Endocannabinoid System in Extinction of Learned Behaviours Motivated by Opioid-Induced Reward and Aversion in Rats

  2013influential citation
• Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

  2013cites this paper
• Kannabinoid tip 1 reseptör (CB1) ve terapötik yaklaşımlara genel bakış-II

  2012cites this paper
• State of the art treatments for cannabis dependence.

  2012cites this paper
• Seekingon Cannabinoids: The Role of Dopamine Release in Reward

  2012cites this paper
• Role of the Endocannabinoid System in the Neurobiology of Suicide

  2012cites this paper
• A brain on cannabinoids: the role of dopamine release in reward seeking.

  2012cites this paper
• Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys

  2012cites this paper
• Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems

  2012cites this paper
• Neurochemical basis of cannabis addiction.

  2011cites this paper
• Altered Mesolimbic Dopamine System in THC Dependence

  2011cites this paper
• PRECLINICAL STUDY: FULL ARTICLE: Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence

  2010cites this paper
• Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.

  2010cites this paper
• Potential Pharmacotherapies for Cannabis Dependence

  2010cites this paper
• Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.

  2010cites this paper
• Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

  2010cites this paper
• Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence

  2009cites this paper
• Role of the Endocannabinoid System in Alcohol-Related Behaviors

  2009cites this paper
• Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

  2009cites this paper
• Candidate genes for cannabis use disorders: findings, challenges and directions.

  2009cites this paper
• Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence

  2009cites this paper
• Basic neuroanatomy and neuropharmacology of cannabinoids

  2009cites this paper
• Locomotor effects of morphine or alcohol in mice after a repeated treatment with the cannabinoid agonist HU 210.

  2008cites this paper
• Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor

  2008cites this paper
• Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.

  2008cites this paper
• [Neuropsychopharmacology of delta-9-tetrahydrocannabinol].

  2008cites this paper
• Spontaneous eyeblink rate predicts the strength of visuomotor binding.

  2007cites this paper
• Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate

  2007cites this paper
• A COMPARISION OF DELTA-9-TETRAHYDROCANNABINOL DEPENDENCE IN C57Bl/6j MICE AND FATTY ACID AMIDE HYDROLASE KNOCK OUT MICE

  2007cites this paper
• MDMA attenuates THC withdrawal syndrome in mice

  2007cites this paper
• Previous Exposure to THC Alters the Reinforcing Efficacy and Anxiety-Related Effects of Cocaine in Rats

  2007cites this paper
• Avaliação do efeito de um extrato lipofílico de Hypericum caprifoliatum Cham.& Schltdl sobre os níveis cerebrais de dopamina e seus metabólitos através de microdiálise cerebral em ratos conscientes

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cites this paper
• Antagonismo del Sistema Endocanabinoide: Implicaciones en el tratamiento de la obesidad, síndrome metabólico y adición a drogas

  2006cites this paper
• Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebusmonkeys

  2006cites this paper
• Endocannabinoids and Dopamine-Related Functions in the CNS

  2005cites this paper
• Endocannabinoid signaling system and brain reward: emphasis on dopamine.

  2005influential citation
• Self-administration of cannabinoids by experimental animals and human marijuana smokers.

  2005cites this paper
• Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.

  2005cites this paper
• Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders

  2005cites this paper
• Novel Pharmacological Treatment Alternatives for Nicotine Dependence av

  2005cites this paper
• Cannabinoid tolerance and dependence: a review of studies in laboratory animals.

  2005cites this paper
• Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence

  2005influential citation
• Novel Pharmacological Treatment Alternatives for Nicotine Dependence

  2005cites this paper
• Cannabinoids and drugs of abuse

  2005cites this paper
• The dopamine hypothesis of drug addiction: hypodopaminergic state.

  2005influential citation
• Le nouveau paysage du cannabis I. Données récentes sur la neurobiologie des endocannabinoïdes et du cannabis

  2004cites this paper
• Amphetamine effects on dopamine levels and behavior following cannabinoid exposure during adolescence.

  2004cites this paper
• The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.

  2004cites this paper
• CHRONIC CANNABIS USE AND ATTENTION- MODULATED PREPULSE INHIBITION OF THE STARTLE REFLEX IN HUMANS

  2004cites this paper
• Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data

  2003influential citation
• The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

  2003cites this paper
• Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats.

  2002cites this paper
• Addictive potential of cannabinoids: the underlying neurobiology.

  2002cites this paper
• Addictive Basis of Marijuana and Cannabinoids

  2002cites this paper
• The relative contributions of ecstasy and cannabis to cognitive impairment

  2001cites this paper
• Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.

  2001cites this paper
• Behavioral sensitization to WIN55212.2 in rats pretreated with heroin.

  2001cites this paper
• Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction.

  2001cites this paper
• Addiction and withdrawal--current views.

  2001cites this paper
• Effets comportementaux des cannabinoïdes Données animales

  2001cites this paper
• [Characteristics of abnormal behavior induced by delta 9-tetrahydrocannabinol in rats].

  2001cites this paper